Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 12902856)

1.

Development of COX inhibitors in cancer prevention and therapy.

Umar A, Viner JL, Anderson WF, Hawk ET.

Am J Clin Oncol. 2003 Aug;26(4):S48-57. Review.

PMID:
12902856
2.

NSAIDs and chemoprevention.

Rao CV, Reddy BS.

Curr Cancer Drug Targets. 2004 Feb;4(1):29-42. Review.

PMID:
14965265
3.
4.

Use of NSAIDs for the chemoprevention of colorectal cancer.

Herendeen JM, Lindley C.

Ann Pharmacother. 2003 Nov;37(11):1664-74. Review.

PMID:
14565811
5.

COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.

Saha D, Pyo H, Choy H.

Am J Clin Oncol. 2003 Aug;26(4):S70-4. Review.

PMID:
12902860
6.

Cancer and cyclooxygenase-2 (COX-2) inhibition.

Evans JF, Kargman SL.

Curr Pharm Des. 2004;10(6):627-34. Review.

PMID:
14965325
8.

Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.

Moran EM.

J Environ Pathol Toxicol Oncol. 2002;21(2):193-201. Review.

PMID:
12086406
9.

The role of cyclooxygenase inhibitors in cancer prevention.

Anderson WF, Umar A, Viner JL, Hawk ET.

Curr Pharm Des. 2002;8(12):1035-62. Review.

PMID:
11945150
10.

Clinical pharmacology of selective COX-2 inhibitors.

Capone ML, Tacconelli S, Sciulli MG, Patrignani P.

Int J Immunopathol Pharmacol. 2003 May-Aug;16(2 Suppl):49-58. Review.

PMID:
14552704
11.

COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs.

Moore BC, Simmons DL.

Curr Med Chem. 2000 Nov;7(11):1131-44. Review.

PMID:
11032963
12.
13.

Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention.

Menter DG.

Expert Opin Investig Drugs. 2002 Dec;11(12):1749-64. Review.

PMID:
12457435
15.

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

Gupta RA, Dubois RN.

Nat Rev Cancer. 2001 Oct;1(1):11-21. Review.

PMID:
11900248
16.

Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse.

Milas L.

Semin Radiat Oncol. 2001 Oct;11(4):290-9. Review.

PMID:
11677654
17.

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.

Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.

Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.

18.

COX-2 inhibitors as radiosensitizing agents for cancer therapy.

Davis TW, Hunter N, Trifan OC, Milas L, Masferrer JL.

Am J Clin Oncol. 2003 Aug;26(4):S58-61. Review.

PMID:
12902857
19.

Cancer research. Anti-inflammatories inhibit cancer growth--but how?

Marx J.

Science. 2001 Jan 26;291(5504):581-2. No abstract available.

PMID:
11233414
20.

Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention.

Basler JW, Piazza GA.

J Urol. 2004 Feb;171(2 Pt 2):S59-62; discussion S62-3. Review.

PMID:
14713756
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk